OasisLMS

ACMG Education Webinar Series: Translating Genes into Health®

 Specialized events developed by ACMG Committees

Course Description

The ACMG Webinar Series: Translating Genes into Health® is a collaborative educational initiative designed to showcase the expertise and contributions of ACMG committees while addressing emerging and impactful topics in medical genetics and genomics. This series provides a platform for thought leaders, researchers, and clinicians to engage in meaningful discussions on advancements in genetic testing, clinical applications, ethical considerations, and health equity.

Through interactive, expert-led sessions, participants will gain valuable insights into cutting-edge research, translational genomics, and best practices in patient care. Each session is developed in collaboration with ACMG committees, reflecting their ongoing efforts to shape the future of clinical genetics through education, policy, and innovation.

2025 Webinar Series:

Target Audience

This activity is designed for clinical geneticists, genetic counselors, laboratory professionals, and other healthcare providers involved in the diagnosis and management of genetic conditions. The content is also relevant to researchers and healthcare professionals seeking to stay up to date on emerging advancements and best practices in genetic conditions.

Learning Objectives

At the conclusion of this series, participants should be able to:

• Apply the latest advancements in clinical genetics and genomics to improve patient care, including innovations in gene therapy, diagnostic transcriptome RNA sequencing, and variant classification.
• Evaluate funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI) and identify strategies for supporting historically underserved patient populations through research initiatives.
• Interpret complex genetic findings and assess their clinical utility, limitations, and implications for patient management.
• Analyze ethical principles and challenges in genetic and genomic medicine, ensuring responsible and equitable application of genetic testing and counseling.
• Engage with ACMG committees to gain insights into emerging research, best practices, and collaborative efforts that shape the future of medical genetics and genomics

Presenters

	Anna Hurst, MD, MS, FACMG University of Alabama at Birmingham
	Margaret Adam, MD, MS, FAAP, FACMG Seattle Children's Hospital

Vanina Taliercio, MD University of Utah

	Brittany Simpson, MD, FACMG St. Jude Children's Research Hospital
	Fabiola Quintero-Rivera, MD, DABMGG, FACMG School of Medicine, University of California Irvine (UCI)
	Gloria Sheynkman, PhD University of Virginia
	Peter  J. Castaldi, MD, MSc Harvard Medical School
	Paola Giusti-Rodriguez, PhD University of Florida
	Mina Ryten, MD, PhD University College London
	Colette Felton, PhD University Of California Santa Cruz
	Henry J. Mroczkowski, MD, PhD, FACMG (Chair) University of TN Health Science Ctr
	Sydney Strickland, PhD, DABCC, FADLM Board member of the Pediatric Maternal Fetal Medicine Division of ADLM
	Nancy Leslie, MD Cincinnati Children’s Hospital
	Anna Scott, PhD, FACMG Seattle Children’s Hospital
	Heather E. Williams, PhD, MBA, MS, FACMG Co-Founder & Principal Consultant Medical Director GeneBetween
	Karen A. Robinson, MPA Senior Advisor, Equity Research and Innovation Center Yale School of Medicine
	Chris Kelly BGR Group
	Senator Daniel Zilkinov Montana State Legislature
	Julie Neidich, MD, FACMG Professor of Pathology and Immunology, Division of Genomics and Molecular Pathology, and of Pediatrics, Division of Genetics and Genomics Washington University in St. Louis (WashU Medicine)

Accredited Continuing Education Information:

CME AMA PRA Category 1^TM, ASCLS P.A.C.E.^®

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The American College of Medical Genetics and Genomics designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

ASCLS P.A.C.E.® CEU's 

ACMG is approved as a provider of continuing education programs in the clinical laboratory sciences by the American Society for Clinical Laboratory Science (ASCLS) Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program.

ACMG is approved by the Florida Board of Clinical Laboratory Personnel as CE Provider (50-11878). ). This course is registered with CEBroker # 20-1320630. ACMG is approved by the California Department of Health Services through the ASCLS P.A.C.E.® (275-300-25). This activity has been approved for 8.5 P.A.C.E.® CEU's.

Claiming your Educational Credits

Complete the activity and carefully complete the evaluation form. The deadline to claim educational credits is within 30 days from the date of the activity. Educational credit requests after this date will not be accepted. 

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

Technical Support:
You can reach us by email at education@acmg.net or call 301-718-9603.
Support Center Hours: Monday – Friday, 9:00 AM – 5:00 PM Eastern Time.

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.

*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACMG Education Policies

Please review the policies below regarding the ACMG Education program

• Financial Disclosures and Mitigation Procedure
• ACMG Content Validation Policy
• ACMG Content Branding Policy

All of the relevant financial relationships listed for these individuals have been mitigated.